Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75:799–810.

Article  PubMed  Google Scholar 

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63:486–92.

Article  PubMed  Google Scholar 

Lim E, Kumar S, Seager M, Modi S, Mandal I, Neves JB, et al. Outcomes of renal tumors treated by image-guided percutaneous cryoablation: immediate and 3- and 5-year outcomes at a regional center. AJR Am J Roentgenol. 2020;215:242–7.

Article  PubMed  Google Scholar 

Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Intervent Radiol. 2017;40:177–91.

Article  PubMed  Google Scholar 

Correas J-M, Delavaud C, Gregory J, Le Guilchet T, Lamhaut L, Timsit M-O, et al. Ablative therapies for renal tumors: patient selection, treatment planning, and follow-up. Semin Ultrasound CT MR. 2017;38:78–95.

Article  PubMed  Google Scholar 

Garnon J. The money time for decision-making. Cardiovasc Intervent Radiol. 2021;44:901–2.

Article  PubMed  Google Scholar 

Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol [Internet]. 2022 [cited 2022 Aug 25]; https://www.sciencedirect.com/science/article/pii/S0302283822016761

Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol Elsevier. 2019;30:706–20.

Article  CAS  Google Scholar 

Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Interv Radiol. 2017;40:177–91.

Article  Google Scholar 

Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging <sup/>. Radiographics. 2010;30:887–900.

Article  PubMed  Google Scholar 

De Marini P, Cazzato RL, Garnon J, Dalili D, Leonard-Lorant I, Leclerc L, et al. Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers. Diagn Interv Imaging. 2021;102:531–8.

Article  PubMed  Google Scholar 

Koch G, Cazzato RL, Caudrelier J, Cathelineau X, Lang H, Gangi A. Techniques d’ablation tumorale. Prog En Urol. 2017;27:853–64.

Article  CAS  Google Scholar 

Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—A 10-year update. Radiology. 2014;273:241–60.

Article  PubMed  Google Scholar 

Lee H-J, Chung H-J, Wang H-K, Shen S-H, Chang Y-H, Chen C-K, et al. Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation. Br J Radiol. 2016;89:20160151.

Article  PubMed  PubMed Central  Google Scholar 

Kawamoto S, Solomon SB, Bluemke DA, Fishman EK. Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation. Semin Ultrasound CT MRI. 2009;30:67–77.

Article  Google Scholar 

Durack JC, Richioud B, Lyon J, Solomon SB. Late emergence of contrast-enhancing fat necrosis mimicking tumor seeding after renal cryoablation. J Vasc Interv Radiol JVIR. 2014;25:133–7.

Article  PubMed  Google Scholar 

Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria RJ. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics. 2007;27:325–39.

Article  PubMed  Google Scholar 

Garnon J, Tricard T, Cazzato RL, Cathelineau X, Gangi A, Lang H. Traitement ablatif pour cancer du rein: modalités d’évaluation pré-, per-, post-intervention et prise en charge adaptée. Prog En Urol. 2017;27:971–93.

Article  CAS  Google Scholar 

Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the american college of radiology and the national kidney foundation. Radiology. 2020;294:660–8.

Article  PubMed  Google Scholar 

Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:706–20.

Article  CAS  PubMed  Google Scholar 

Laimer G, Jaschke N, Schullian P, Putzer D, Eberle G, Solbiati M, et al. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases. Eur Radiol. 2021;31:6489–99.

Article  PubMed  PubMed Central  Google Scholar 

Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures. They Are Data Radiology. 2016;278:563–77.

PubMed  Google Scholar 

Tsili AC, Andriotis E, Gkeli MG, Krokidis M, Stasinopoulou M, Varkarakis IM, et al. The role of imaging in the management of renal masses. Eur J Radiol. 2021;141: 109777.

Article  PubMed  Google Scholar 

Li A, Xing W, Li H, Hu Y, Hu D, Li Z, et al. Subtype Differentiation of small (≤ 4 cm) solid renal mass using volumetric histogram analysis of DWI at 3-T MRI. AJR Am J Roentgenol. 2018;211:614–23.

Article  PubMed  Google Scholar